19^TH January 2010 Cambridge, UK – BioWisdom. a provider of specialist medical metadata and Intelligence Solutions for Healthcare, is pleased to announce the publication of an exciting new paper in Chem. Res. Toxicol. Using metadata derived from BioWisdom’s Safety Intelligence Program, Alex Tropsha and colleagues at the University of North Carolina have applied QSAR modelling and other chemoinformatics techniques to qualitative assertions abstracted from legacy data.

Read more about Old Data, New Insight »

BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that it has released of Version 3 of its award-winning Safety Intelligence Program.

Read more about BioWisdom Announces Release of Safety Intelligence Program Version 3.0 »

20 May 2009, Cambridge, UK – BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announces that its Safety Intelligence Program has been awarded a prestigious “Best Practices” award at the recent Bio-IT World Life Sciences Conference and Expo in Boston.

Read more about BioWisdom’s Safety Intelligence Program Win’s ‘Best Practice’ Award for... »

BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today announced that AstraZeneca, one of the world’s leading pharmaceutical companies, has selected them to apply the Sofia platform to generate a rich vocabulary and assertional meta-data from thousands of AstraZeneca-owned toxicology reports.

Read more about Biowisdom Selected by AstraZeneca to Create Custom Vocabulary Assertional... »

24 February 2009, Cambridge, UK – BioWisdom Ltd (BioWisdom), a market leader in delivering healthcare intelligence to the pharmaceutical industry, today launches version 2 of their KnowledgeScan service.

Read more about BioWisdom Launches Version 2 of KnowledgeScan and Secures First... »

Asterand plc (LSE: ATD), a leading provider of human tissue and services to pharmaceutical companies engaged in drug discovery research, and BioWisdom Ltd, a market leader in delivering healthcare intelligence to the pharmaceutical industry, announce that the Companies have entered into a data syndication agreement to provide value added delivery of Asterand’s human gene expression profiles through BioWisdom’s intelligence solutions. Terms of the agreement were not disclosed.

Read more about Asterand and BioWisdom Announce Data Syndication Agreement »